Mandate

Vinge advises AcadeMedia in connection with the public offer from Providence

April 22, 2010

Vinge advises AcadeMedia AB (publ) ("AcadeMedia") in connection with the public offer from Providence for all outstanding shares in AcadeMedia, which was announced on 22 April 2010. Providence offers SEK 170 for each share in AcadeMedia and the total value of the offer amounts to SEK 2,050 million. Providence has received undertakings to accept the offer from some of the major shareholders in AcadeMedia, who together own shares corresponding to approximately 17.4 per cent of all outstanding shares and votes in AcadeMedia. The offer is recommended by the bid committee of AcadeMedia which has been appointed in connection with the offer.
 
AcadeMedia is the largest education company in Sweden. AcadeMedia currently has approximately 45,000 students and course attendants, in excess of 100 schools and around 2,500 employees with operations within the entire Swedish education area: pre-, compulsory-, and upper secondary schools and within adult education. The operations are conducted through independent schools and companies such as Vittra, NTI, Rytmus, IT-Gymnasiet, Ljud & Bildskolan and Mikael Elias Teoretiska Gymnasium. AcadeMedia is listed on NASDAQ OMX Stockholm, Small Cap.

Vinge's team consists of Göran Nyström and Dain Nevonen. Erik Sjöman and Jesper Schönbeck have advised in certain matters related to capital markets law.
 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024